To address these discrepancies, we conducted a systematic review and meta-analysis to combine the results of previous studies, in order to yield a more accurate estimation on the association between CYP2E1 polymorphisms and CRC risk. This evidence concerns the gene CYP2E1 and colorectal carcinoma.